Phase I trial of oral vorinostat (suberoylanilide hydroxamic acid, SAHA) in patients with advanced multiple myeloma
Richardson, Paul, Mitsiades, Constantine, Colson, Kathleen, Reilly, Eileen, McBride, Laura, Chiao, Judy, Sun, Linda, Ricker, Justin, Rizvi, Syed, Oerth, Carol, Atkins, Barbara, Fearen, Ivy, Anderson, Kenneth, Siegel, David
Published in Leukemia & lymphoma (01.01.2008)
Published in Leukemia & lymphoma (01.01.2008)
Get full text
Journal Article
Combination of Vorinostat Plus Bortezomib for the Treatment of Patients with Multiple Myeloma Who Have Previously Received Bortezomib
Weber, Donna M., Jagannath, Sundar, Sobecks, Ronald, Schiller, Gary, Chiacchierini, Lisa, Reiser, David, Oerth, Carol, Garcia-Vargas, Jose, Rizvi, Syed
Published in Blood (16.11.2008)
Published in Blood (16.11.2008)
Get full text
Journal Article
Final Results of a Phase I Trial of Oral Vorinostat (Suberoylanilide Hydroxamic Acid, SAHA) in Patients with Advanced Multiple Myeloma
Richardson, Paul G., Mitsiades, Constantine S., Colson, Kathleen, Reilly, Eileen, McBride, Laura, Chiao, Judy, Sun, Linda, Ricker, Justin L., Rizvi, Syed, Oerth, Carol, Atkins, Barbara, Fearen, Ivy, Anderson, Kenneth C., Siegel, David S.
Published in Blood (16.11.2007)
Published in Blood (16.11.2007)
Get full text
Journal Article
Phase I Trial of Oral Vorinostat (Suberoylanilide Hydroxamic Acid, SAHA) in Combination with Bortezomib in Patients with Advanced Multiple Myeloma
Weber, Donna M., Jagannath, Sundar, Mazumder, Amitabha, Sobecks, Ronald, Schiller, Gary J., Gavino, Maria, Sumbler, Chantelle, McFadden, Carrie, Chen, Cong, Ricker, Justin L., Rizvi, Syed, Oerth, Carol, Brownell, Patricia, Hussein, Mohamad A.
Published in Blood (16.11.2007)
Published in Blood (16.11.2007)
Get full text
Journal Article